Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00282191
Status:
COMPLETED
Last Update Posted:
2008-03-28
First Post:
2006-01-23
Brief Title:
Prevalence of Spasticity in Adults With Mental Retardation Living in the Community
Sponsor:
Vanderbilt University
Organization:
Vanderbilt University
Study Overview
Official Title:
Prevalence of Spasticity in Adults With Mental Retardation Residing in a Community Setting
Status:
COMPLETED
Status Verified Date:
2008-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This survey aims to investigate the prevalence of spasticity among adults who live in community settings in Davidson County Tennessee The treatment of spasticity in those who live in community homes could significantly increase a persons quality of life by allowing them to participate more independently in activities of daily living or by making assistance easier for caregivers
Detailed Description:
The process of deinstitutionalization has transitioned a large majority of persons with developmental disabilities into the community over the past several decades and that number will only increase going forward There are 926 people in this region who are provided assistance through the Division of Mental Retardation Services DMRS People with developmental disabilities frequently have comorbidities such as spasticity that hinder their ability to participate in activities of daily living Spasticity results from brain or spinal cord injury and can produce increased muscle tone causing joint stiffness contractures and pain that can interfere with recommended treatment A previous survey conducted at Clover Bottom Developmental Center investigated care areas typically affected by spasticity including splinting hygiene dressing transfers positioning ambulation and engaging in other functional activities Pfister et al reported the prevalence of spasticity in the developmental center to be 35 72205 of those people the Survey Physician felt that 75 5472 would achieve a functional benefit from treatment
Primary endpoints will assess the prevalence of spasticity in adults who reside in the community and whether or not spasticity impacts activities of daily living When appropriate potential care area goals will be identified and treatment options will be recorded Secondary endpoints will examine whether or not participants currently receive treatment for spasticity if so what treatment is being used and which care areas are most impacted by spasticity
Primary endpoints will assess the prevalence of spasticity in adults who reside in the community and whether or not spasticity impacts activities of daily living When appropriate potential care area goals will be identified and treatment options will be recorded Secondary endpoints will examine whether or not participants currently receive treatment for spasticity if so what treatment is being used and which care areas are most impacted by spasticity
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None